Celebrating Women in Life Sciences: Driving Discovery, Innovation and Change
08 Mar, 20264 minutesScientific progress has always depended on bold ideas, but also on the people courageous eno...
Scientific progress has always depended on bold ideas, but also on the people courageous enough to pursue them.
Across laboratories, biotech startups and global research institutes, women have played a defining role in shaping modern life sciences. From decoding the building blocks of DNA to leading the development of next-generation therapeutics, their work continues to drive discovery and innovation across the sector.
Yet the full potential of women in science is still unfolding. Today, women make up only around one-third of researchers worldwide, according to data from UNESCO.
That statistic highlights both the progress made and the opportunity ahead.
This International Women’s Day and throughout Women’s History Month, the life sciences community has an opportunity to celebrate the pioneers who built the foundations of modern science, recognise the leaders shaping the industry today, and continue building a sector where talent and innovation can thrive without barriers.
Women Leading Today’s Scientific Breakthroughs
Women’s influence in life sciences is increasingly visible across research institutes, biotech companies and global healthcare organisations.
Recognition programmes such as the Fierce Women in Life Sciences Awards celebrate leaders driving innovation across drug development, biotechnology platforms and healthcare delivery.
International initiatives are also helping accelerate female scientific leadership. The L’Oréal-UNESCO For Women in Science Programme has supported more than 4,400 female researchers across over 140 countries, helping amplify groundbreaking research and career progression.
Support for female founders is also growing. The Innovate UK Women in Innovation Awards continue to back women-led companies developing transformative technologies across biotech and healthtech.
Despite this momentum, funding gaps remain significant.
Across Europe, female founders raised just 12% of total venture capital investment in 2024, even as the number of women-led deep-tech companies continues to grow.
This matters because diverse leadership consistently drives stronger innovation outcomes. Studies show companies founded by women can generate significantly higher revenue per dollar invested compared with male-founded companies.
Women are not simply participating in life sciences, they are actively shaping the future of the industry, from precision medicine and cell therapies to antimicrobial research and digital health innovation.
Confronting Barriers and Creating Meaningful Progress
While progress is clear, structural barriers continue to shape career pathways across the life sciences sector.
Globally, women represent approximately 33% of the research workforce, yet their representation often declines at senior leadership levels.
In biotech entrepreneurship, the disparity is even more pronounced. Female-founded companies still receive only a small fraction of venture capital investment, despite evidence that diverse founding teams often outperform their peers.
Leadership data within the biotech sector reflects similar trends. Women currently hold less than one-fifth of CEO roles in biotech companies, and female-led firms account for a relatively small share of total industry investment.
Career progression in science is shaped by multiple factors, including access to major research grants, authorship recognition and speaking opportunities at global conferences. Implicit bias and unequal caregiving responsibilities can further influence these trajectories.
However, the industry is beginning to respond.
Professional communities such as Women in Pharma are building networks that support mentorship, collaboration and leadership development.
Meanwhile, global initiatives like the International Day of Women and Girls in Science continue to highlight the importance of closing gender gaps across STEM fields.
Increasingly, organisations are recognising that inclusion is not simply a social priority; it is a scientific and economic advantage.